The blood, and blood composition, Lecture notes of Anatomy

Blood levels, and blood anatomy at the cellular level

Typology: Lecture notes

2025/2026

Uploaded on 06/28/2026

emerance-kitenge
emerance-kitenge 🇨🇦

5 documents

1 / 19

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
February, 22, 2026
Blood
Cardiovascular review
The main transport system
Consists of the heart and the blood vessels through which the blood
flows in the body
Three types of blood vessels which blood flows: arteries, veins, and
capillaries
Function of the blood
1. Transportation: Hormones, CO2 and wastes, O2 and nutrients
2. Protection: clot formation against infection
3. Regulation: PH, Body temperature, fluid volume
Composition of Blood
Characteristics
Scarlet = O2 rich, Dark red =O2 poor
More dense, viscous than water
PH 7.35-7.45, temperature 38C
8% body weight (5-6 liters in males, 4-5 liters in females)
Components
The ONLY fluid tissues in the
body
Erythrocytes (RBCs)
Leucocytes (WBCs)
Platelets
Image is blood once
centrifuged
Blood Plasma
55% of whole blood
90% water
Composition of Plasma *TABLE
Water
Electrolytes
Plasma proteins (Albumin,
Globulins, Fibrinogen)
Nonprotein nitrogenous
substances
Nutrients (organic)
Respiratory gases
Hormones
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13

Partial preview of the text

Download The blood, and blood composition and more Lecture notes Anatomy in PDF only on Docsity!

Blood Cardiovascular review  The main transport system  Consists of the heart and the blood vessels through which the blood flows in the body  Three types of blood vessels which blood flows: arteries, veins, and capillaries Function of the blood

  1. Transportation: Hormones, CO2 and wastes, O2 and nutrients
  2. Protection: clot formation against infection
  3. Regulation: PH, Body temperature, fluid volume Composition of Blood Characteristics  Scarlet = O2 rich, Dark red =O2 poor  More dense, viscous than water  PH 7.35-7.45, temperature 38C  8% body weight (5-6 liters in males, 4-5 liters in females) Components  The ONLY fluid tissues in the body  Erythrocytes (RBCs)  Leucocytes (WBCs)  Platelets  Image is blood once centrifuged Blood Plasma  55% of whole blood  90% water Composition of Plasma *TABLE  Water  Electrolytes  Plasma proteins (Albumin, Globulins, Fibrinogen)  Nonprotein nitrogenous substances  Nutrients (organic)  Respiratory gases  Hormones

Which protein contribute most for plasma osmotic pressure? Albumin is the plasma protein that contributes most to plasma osmotic pressure (specifically colloid osmotic/oncotic pressure). As the most abundant plasma protein (60% of total protein), it maintains fluid balance by holding water inside blood vessels, preventing edema. Summary of Formed Elements ** Leukocytes  Only formed element that is a complete cell  Function in defense against diseases , <1% of total blood volume  Granulocytes contain visible cytoplasmic granules, phagocytic  Agranulocytes lack visible cytoplasmic granules  Types

 Formation of all blood cells; red cells, white cells, and platelets—from hematopoietic stem cells, primarily within the red bone marrow  The Reticular CT contains: immature blood cells, macrophages, fat cells, reticular cells  Hemocytoblasts = stem cells for all formed elements = cells become committed Erythropoiesis  Erythrocyte (RBC) formation Stages explained  begins when a hematopoietic stem cell descendant called a myeloid stem cell transforms into a proerythroblast  proerythroblasts give rise to basophilic erythroblasts that produce huge numbers of ribosomes  cells divide many times during first two phases  Hemoglobin is synthesized and iron accumulates as the basophilic erythroblast transforms into  polychromatic erythroblast  then orthochromatic erythroblast  orthochromatic ejects its nucleus = Reticulocyte (young rbc w clumps of ribosomes)  because nucleus ejected, shape collapses into a biconcave shape and becomes a true erythrocyte  process takes 15 days to get to reticulocyte  then 2 days to finally become mature erythrocyte after ribosomes are degraded by intracellular enzymes  Reticulocyte vs Erythrocyte

o Reticulocyte = immature red blood cells released from bone marrow, and contains some RNA residual = bursting of hemoglobin o Erythrocyte = fully mature red blood cells = no nucleus = biconcave = carries oxygen and carbon dioxide Hormonal Control of Erythropoiesis  Erythropoietin (EPO) – Glycoprotein produced in the Kidneys  There’s always some EPO circulating the blood  More EPO would be released by the kidneys if a patient was hypoxic  Blood oxygen levels can drop by; excessive bleeding, insufficient Hb per RBC (as in iron deficiency), reduced availability of oxygen at high altitude or during pneumonia  Athletes & EPO abuse  EPO hematocrit from 45% to 65%, stamina & performance  blood viscosity + dehydration during race can  clotting, stroke or heart failure  Testosterone also enhances the Kidney’s production of EPO which could be responsible for high RBC count and hemoglobin levels we see in males Blood viscosity increases due to elevated red blood cell count (polycythemia), dehydration, high plasma protein levels (e.g., fibrinogen, immunoglobulins), reduced red blood cell flexibility, and smoking. Dietary Requirement  Materials required for erythropoiesis:  Amino acids, lipids, and carbohydrates  Iron: available from diet o 65% of the iron in hemoglobin the rest in liver, spleen, and bone marrow o Free ions = toxic so iron is bound to proteins o Iron is stored in cells as ferritin & hemosiderin o Iron Is transported in blood by being bound to protein transferrin  Vitamin B12 and folic acid are needed for DNA synthesis of rapidly dividing cells like RBC’s Life Cycle of RBC  Life span = 100-120 days  Old RBCs become fragile b/c they get trapped and break apart in smaller circulatory channels, especially those in the spleen.  That’s why the spleen is called “RBC graveyard”

 Polycythemia vera: Bone marrow cancer leading to excess RBCs  Hematocrit may go as high as 80% (more RBCs dividing then usual)  Treatment: therapeutic phlebotomy (blood draw)  Secondary polycythemia: caused by any condition that stimulates EPO production (like low O2 levels at high altitude or medication)  Abnormal excess of RBCs = high blood viscosity  sluggish blood flow Platelets  Cytoplasmic fragments of megakaryocytes  Anucleate  Blue stained outer region  Purple-stained granules contain serotonin, Ca2, enzymes, ADP, & platelet-derived growth factor (PDGF) – Act in clotting process  Normal 150,000-400,000 platelets/ml of blood  Life span = 10 days  Location of Platelets Formation  Bone: megakaryocytes send cytoplasmic projections into red bone marrow capillaries (sinusoids) = breaks off into platelets  Lungs: large megakaryocyte fragments or whole ones enter marrow  travel to the lungs  and get trapped in smaller pulmonary capillaries = fragment into more platelets  accounts for more than half of the platelets in circulation Hemostasis  Process of blood stoppage after blood vessel injury  Requires clotting factor & substance released by platelets & injured tissues  Steps:

  1. Vascular spasm
  2. Platelet plug formation
  1. Coaugulation (blood clotting) Vascular Clotting  Vasoconstriction of vessel in response to damage  Its purpose is to reduce blood loss, allowing time for steps 1 & 2 to occur  Triggered by:  damage to vascular smooth muscles  chemicals from endothelial cells & platelets  Pain receptor reflexes  Most effective in smaller blood vessels Platelet Plug formation  Normally conditions: o platelets don’t stick to each other or endothelial cells o nitric oxide (NO) & prostacyclin (PGI2) secreted by endothelial cells act to prevent platelet aggregation  ensures that clotting only happens where and when its needed o Intact endothelial cells release nitric oxide and prostacyclin. Both chemicals prevent platelet aggregation (clumping) in undamaged tissue and restrict aggregation to the site of injury. o ** if platelets aggregated consistently without injury it would lead to pathologic thrombosis, vessel occlusion, ad infarction (stroke, heart attack)  When vessels are damage: o Platelets stick to exposed collagen fibers o Von Willebrand factors help to stabilize platelet-collagen adhesion o Platelet becomes activated  swells  becomes spikes and stickier  and then releases chemical messengers  Adenosine diphosphate (ADP ) = cases more platelet aggregation by allowing them to stick to the area  Serotonin & thromboxane A2 = promote vascular spasm & spasm aggregation o More platelets aggregate = release more chemicals = aggregates even more platelets = positive feedback loop Coagulation

Phase 3: Pathway to the fibrin mesh  Thrombin converts soluble fibrinogen  fibrin which forms fibrin polymer = causes plasma to become a gel-like trap catching formed element  Thrombin (and Ca2+) activates XIII ( fibrin stabilizing factor) = crosslinks fibrin strands to fibrin mesh = structural clot  further strengthens and stabilizes clot  Clot formation complete in 3-6 minutes post injury Anticoagulants  Substances that inhibit clotting  Clot formation depends on balance between procoagulants and anticoagulants  They dominate to prevent clotting (except in area of damage) Clot Retraction & Fibrinolysis  Clot retraction – actin and myosin platelets contract within 30-60 mins = pulls on fibrin strands, squeezes serum from clot = draws ruptured blood vessel edges together  Repair – platelet derived growth factors stimulate division of smooth muscle cells & fibroblast to rebuild wall of vascular endothelial growth factor (VEGF) = stimulates endothelial cells to multiply and restore the lining  Fibrinolysis – process of clot removal after completed repair  Begins within 2 days and continues serval days after until clot is dissolved  Plasminogen converted to plasmin by tissuePlaminogenActivator, XIIa, thrombin Limiting Clot Growth or Formation

Fibrin

XIIa Thrombin

Plasmin

(active enzyme)

Endothelial cells

tPA

Fibrin

degrades

Plasminogen

(inactive

precursor)

 Factors limiting normal clot growth Ø Mechanisms limiting clot size:  Swift removal and dilution of clotting factors  Inhibition of activated clotting factors Ø Clot forms thrombin, which is bound to fibrin threads, limiting size of clot  Antithrombin III (plasma protein) inactivates unbound thrombin  Heparin inhibits thrombin by enhancing activity of anithrombin III  Factors preventing undesirable clotting  Platelets not clinging to smooth, intact endothelial lining of blood vessel  Endothelial cells secrete antithrombic substances: nitric oxide & prostacyclin  Contact activation – clot coming in contact with blood flowing normally Hemostasis Disorder  Thromboembolic conditions Ø Thrombi and emboli Thrombus = clot that develops and persists in unbroken vessel Embolus= thrombus freely floating in blood stream Embolism= embolus obstructing a vessel Ø Anticoagulant drugs: used to prevent undesirable clotting  Bleeding disorders Ø Thrombocytopenia: deficient number of circulating platelets Ø Impaired liver function: unable to synthesize clotting factors Ø Hemophilia: hereditary bleeding disorders  Disseminated Intravascular coagulation (DIC) Ø Widespread clotting in unbroken vessels, followed by severe bleeding o Petechiae occurs due to wide spread hemorrhage (platelet deficiency or dysfunction) Blood transfusion  Cardiovascular system lowers the impacts of blood loss by:

  1. Reducing volume to affect blood vessels
  2. Making more RBCs  Body compensates blood loss to a certain extend  15-30% blood loss = pale and weak  30% blood loss = potential fatal severe shock  Whole blood transfusion = For substantial blood loss  Packed red blood cells (PRBCs) for anemia

Rh Blood Groups  52 Rh antigens or Rh factors ( C,D,E, c, e are common)  Rh+ indicates the presence of D antigen (85% Americans have Rh+) = means that their RBCs carry the D antigen; People (15%) that don’t carry D antigen = Rh- (negative)  Anti-Rh antibodies do not spontaneously form in Rh- o It forms when Rh- person receives Rh+ blood, o Rh- mom is carrying a Rh+ fetus  Second exposure (second birth) results in typical transfusion reaction Hemolytic disease of newborn – erythroblastosis fetalis  Occurs in Rh- mom with Rh+ fetus o 1 st^ pregnancy = mom Rh- is exposed to Rh+ baby, baby born healthy, but mom makes anti-Rh antibodies o 2 nd^ pregnancy = mom’s anti-Rh crosses placenta and destroys RBCs of Rh+ baby – baby treated with prebirth transfusion and transfusions after birth  RhoGAM serum that contains anti-Rh antibody can prevent Rh- from becoming sensitized Transfusion Reactions  Occurs when mismatched blood is infused  Problem: recipient’s plasma antibodies attack donor’s RBC  RBCs first agglutinate and clog small vessels  RBC’s then rupture and Hb is released into blood stream  Results o Diminished oxygen-carrying capacity o Decreased blood flow to blood vessel o Kidney failure  Symptoms: fever, chills, low blood pressure, rapid heartbeat, nausea, vomiting  Treatment: prevent kidney damage with fluids and diuretics to wash out hemoglobin Blood Typing  Blood is mixed with antibodies against common antigens o If antigen is present, clumping of RBCs will occur  Blood is typed for ABO, and for Rh factor in this manner  Cross matching: typing between specific donor & recipient  Mix recipient’s serum with donor’s RBCs  Mix donor’s serum with receipt’s RBCs Developmental Aspects of Blood

 Blood cells develop from collections of mesenchymal cells called blood islands  Fetal blood cells form in yolk sac, liver, and spleen  The fetus forms hemoglobin F, which has higher affinity for O 2 than hemoglobin A formed after birth  Red bone marrow is primary a hematopoietic area by seventh month  Blood diseases of aging  Chronic leukemias, anemias, clotting disorders  Usually precipitated by disorders of heart, blood vessels, or immune system

Life Cycle of RBC

Blood Clotting Factors

Clot formation – Intrinsic & Extrinsic Pathways

Definitions Hematocrit (Hct) - is a blood test measuring the percentage of total blood volume composed of red blood cells. It is a key component of

Go over Blood typing and transfusion Where and what loops does homeostasis have with circulatory system.. with different organs especially kidney, and liver